Beware of Japan's trade ambitions

Japan is pushing for higher levels of intellectual property protection that will cut access to affordable medicines

Drugs pricing policy in limbo

Supreme court delays judgement on case that will help fix prices of essential medicines

Supreme abuse

Bulk drug makers at Patancheru continue to pollute in the absence of effective vigilance, shows an analysis by the Centre for Science and Environment

Government withdraws NPPA’s power to fix prices of non-essential medicines

Prices of cardiac, diabetes, HIV/AIDS drugs likely to be affected

COVID-19 exposes India’s dependence on China for active pharma ingredients

India imports around 90 per cent of APIs used to make antibiotics, says an expert

Antimicrobial resistance: India needs to enhance framework for monitoring antibiotics

Global procurement focus shifting to monitoring drug manufacturing practices  

Profits and not improving accessibility matter to Indian drug makers

FICCI conference organised to discuss access to generic medicines focuses more on increasing exports

Faulty formula

New drug pricing policy proposes bringing all essential medicines under price control, but makes them expensive

Accident at Sainor unit in Vizag more proof of companies bypassing rules

Life-saving equipments were absent on-site though the company had approvals to show they were present

Drug pricing body puts cap on trade margin for 42 anti-cancer drugs

Experts say move will not benefit patients as drug prices are already too high and the cap only negligible

Industries can harm health in many ways: Here are 3 that aren’t so obvious

Some products and practices are directly linked to avoidable ill health, planetary damage and social and health inequity, especially by …

Pharma lobby obtains stay on Centre’s drug price control order

Drug manufacturers also trying to scuttle government’s drug pricing policy

Getting the drug equation right

Sonal Matharu reports how fights over counterfeit drugs and low-quality drugs is suppressing the larger issue of drug safety

Curing the ills of pharma FDI

Foreign investment in existing pharma companies will be allowed with riders

15 doctors went on foreign jaunt sponsored by pharma company, says Lok Sabha member

Doctors and pharma company deny charges

Supreme Court to examine drug pricing policy

Asks Centre about very high profit margins allowed to manufacturers and dealers under Drug Price Control Order for essential medicines

Your toothpaste may cause cancer

A study finds nicotine dental products contain nicotine

Drug pricing policies bent to favour pharma industry, allege health experts

Nearly 83 per cent medicines out of the ambit of price control policy, thus making them out of reach for most patients, say two recent reports

Drug trials: SC pulls up Centre for not compensating victims who suffered severe adverse effects

Asks government to pay victims and recover the money from pharma companies sponsoring the drug trials later

US keeps India out of Priority Foreign Country list of 'worst IP offenders'

US Trade Representative’s Special 301 Report keeps up pressure on India to fall in line with US’ interests

Three pharma units under scanner for exposing workers to polyacrylate hazard

Gujarat High court directs medical check-up of all employees

Diabetes drug ban spells trouble for patients, doctors

Experts say pioglitazone difficult to substitute and health ministry has imposed ban without a back up plan

ACTA fury goes viral

Europe is on the boil over an anti-piracy bill that will curb Internet freedom but its impact on trade in generic medicines is not on the radar

Court revoking ban on cough remedy worries health activists

They say continuing availability of the drug poses health risk

When will Indian scientists unbolt?

Are Indian scientists really too busy to answer emails and phone calls? wonders Dinsa Sachan